companydata.dkcompanydata.dk
SearchPricingAPI
companydata.dkcompanydata.dk

Free company lookup with financials, ownership and key figures for all Danish companies.

Overview

  • Municipalities
  • Postal codes
  • Industries
  • Countries
  • Top 100 companies
  • Top lists
  • Business news
  • Check company
  • Find owner
  • Financial data
  • Credit rating
  • Credit report
  • Background check

Links

  • Search
  • Pricing
  • Company profile
  • Monitoring
  • Lead List Generator
  • CVR Enrichment
  • Network search
  • Statstidende
  • Guides
  • Glossary
  • Compare alternatives

Integrations

  • API
  • MCP-server
  • Claude
  • ChatGPT
  • Perplexity
  • Mistral Le Chat
  • Gemini
  • Zapier
  • Dinero
  • e-conomic

Who it's for

  • For accountants
  • For investors
  • For sales teams
  • For lawyers
  • For journalists

Legal

  • Privacy Policy
  • Terms of Service
  • Information Letter
  • Contact

© 2026 companydata.dk

Aspeya Denmark A/S

CVR: 44838206

Micro companyNewly establishedLoss-making

Secondary names: Vectura Fertin Pharma Denmark A/S

Previous names: Vectura Fertin Pharma Denmark A/S

Active
Own this company?

About Aspeya Denmark A/S

Aspeya Denmark A/S is a Danish company of the type Aktieselskab based in Vejle, founded in 2024. The company is registered under the industry Fremstilling af farmaceutiske præparater. The company was previously named Vectura Fertin Pharma Denmark A/S. The management consists of Christopher Beck Lambert. The company is owned by Aspeya Inc.. In 2025, the company reported a gross profit of DKK -5,816,709 and a net result of DKK -14,892,772. Equity amounted to DKK 2,194,236.

Your company? Claim the profile and show your logo, website and social channels — for free.

Claim this profile

Overview

Company type
A/S
Aktieselskab
Address
Dandyvej 19, 7100 Vejle
VEJLE
7100 Vejle
Find nearby companies
Founded
16.5.2024

Details

Industry
Fremstilling af farmaceutiske præparater
Code: 212000
Capital
500.000 kr.

Purpose

Selskabets formål er at forske, udvikle, fremstille og markedsføre produkter inden for sundhed og velvære samt hermed beslægtet virksomhed, samt at udføre enhver finansiel, kommerciel eller industriel aktivitet, der direkte eller indirekte vedrører formålet.

Location

Google Maps|Apple Maps|OpenStreetMap

Financials

YearGross ProfitProfit/LossTotal AssetsEquityEmployeesReport
2025-5.8 mio.-14.9 mio.7 mio.2.2 mio.2

How creditworthy is Aspeya Denmark A/S?

See the CDS score and get a full credit report with recommended credit limit and payment terms.

Read about the CDS score

Industry Benchmarks

View industry report

Compared to 129 companies in Fremstilling af farmaceutiske præparater

Employees
Company2
Industry median12
6.0x below
Equity ratio
Company31.3%
Industry median62.0%
50% below

Comparison is based on industry median values

Ownership

Owners
Aspeya Inc.
100%
Aspeya Denmark A/S
CVR: 44838206

Management

Directors

Christopher Beck Lambert(DIREKTØR)

Board

Helle Egdal Nielsen(FORMAND)
Christopher Beck Lambert(BESTYRELSESMEDLEM)
Michael Henrik Thomsen(BESTYRELSESMEDLEM)

PEP screening

Screen owners and management against the Danish FSA's official PEP lists

Founders

Aspeya Inc.

Production units (1)

Aspeya Denmark A/S
P-no: 1030364186
Dandyvej 19, 7100, Vejle
Fremstilling af farmaceutiske præparater

Is this your company?

Free

Claim this page to add your logo and social links. Free to get started.

  • Verified badge on your profile
  • Upload your logo
  • Links to your website and social channels

History

12 events
2026
Aspeya Denmark A/S: The 2025 annual report is outJun 23, 2026

Aspeya Denmark A/S has published its annual report for 2025. Gross profit came to DKK -5,816,709, and the net result was DKK -14,892,772.

2025
Aspeya Denmark A/S publishes interim reportJun 25, 2025

Aspeya Denmark A/S has published its interim report for the period May 16, 2024 – December 31, 2024.

Christopher Beck Lambert joins Aspeya Denmark A/S as directorJun 1, 2025

As of June 1, 2025, Christopher Beck Lambert is registered as director of Aspeya Denmark A/S.

Joel Benjamin Rubenstein steps down as director of Aspeya Denmark A/SJun 1, 2025

As of June 1, 2025, Joel Benjamin Rubenstein has stepped down as director of Aspeya Denmark A/S.

Vectura Fertin Pharma Denmark A/S changes name to Aspeya Denmark A/SJan 1, 2025

On January 1, 2025, the company changed its name from Vectura Fertin Pharma Denmark A/S to Aspeya Denmark A/S.

2024
Aspeya Denmark A/S appoints new auditorMay 16, 2024

As of May 16, 2024, PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB has been appointed auditor of Aspeya Denmark A/S.

Christopher Beck Lambert joins the board of Aspeya Denmark A/SMay 16, 2024

As of May 16, 2024, Christopher Beck Lambert has joined the board of directors of Aspeya Denmark A/S.

Michael Henrik Thomsen joins the board of Aspeya Denmark A/SMay 16, 2024

As of May 16, 2024, Michael Henrik Thomsen has joined the board of directors of Aspeya Denmark A/S.

Helle Egdal Nielsen joins the board of Aspeya Denmark A/SMay 16, 2024

As of May 16, 2024, Helle Egdal Nielsen has joined the board of directors of Aspeya Denmark A/S.

Joel Benjamin Rubenstein joins Aspeya Denmark A/S as directorMay 16, 2024

As of May 16, 2024, Joel Benjamin Rubenstein is registered as director of Aspeya Denmark A/S.

Registered as owner of Aspeya Denmark A/SMay 16, 2024

As of May 16, 2024, is registered as an owner of Aspeya Denmark A/S with an ownership share of 100%.

Aspeya Denmark A/S is foundedMay 16, 2024

Aspeya Denmark A/S was founded on May 16, 2024.

Similar companies

Companies in the same industry and area

PHYTORECEPTORS ApS

CVR 35820620

Fremstilling af farmaceutiske præparaterVEJLE0 employees